Our data builds on the limited information available from few smaller studies about the prevalence and biology of co-occurring KRAS mutations in colorectal, gastric and lung cancer patients18–23, where multiple KRAS mutations were detected either in different tumour lesions in the same patient20, distinct cell clones within the same tumour19 or in the same tumour cell22,23. Here, KRAS is linked to neoplasm.